Remicade Data In AS Shows Improvement | Arthritis Information

 

Data presented at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology showed that patients with ankylosing spondylitis (AS) who received REMICADE® (infliximab) over two years experienced significant improvement in spinal mobility. In addition, REMICADE-treated patients showed sustained reductions in spinal inflammation through two years as detected by magnetic resonance imaging (MRI).

 

Good infoI just had my first remicade treatment today.  I was given Methotextrate 2.5mg to work against the build up of antibodies that some develop during remicade treatment.  I am excited, but a bit nervous about what will happen next.  Can anyone share about there early remicade treatments that went well? [QUOTE=Ryan1123] I just had my first remicade treatment today.  I was given Methotextrate 2.5mg to work against the build up of antibodies that some develop during remicade treatment.  I am excited, but a bit nervous about what will happen next.  Can anyone share about there early remicade treatments that went well?[/QUOTE]
Hello friends,,,,,,,,sneha here,,,,Welcome to the forum .....great post,,,,,i like it.....good luck.......
Copyright ArthritisInsight.com